ICM
DNA icon

Ionic Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Ionic Capital Management’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,490
Closed -$828K – 451
2021
Q4 		$828K Buy
+2,490
New +$1.18M 0.11% 180

Other funds holding DNA

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ionic Capital Management's DNA Position: Q2 2023 in Review

Ionic Capital Management sold out of Ginkgo Bioworks (DNA) in Q2 2023, closing a stake of 2,252 shares — an estimated $120K sold.

Ionic Capital Management first reported a position in DNA in Q4 2021 and held it in 2 quarters. The position peaked at $168K in Q4 2021. 315 funds tracked by Wall St. Rank hold DNA as of Q2 2023.

  • Ionic Capital Management reported no remaining Ginkgo Bioworks position as of Q2 2023 after selling out during the quarter.
  • Ionic Capital Management sold 2,252 Ginkgo Bioworks shares in Q2 2023, an estimated $120K.
  • Ionic Capital Management first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 2 quarters.
  • Ionic Capital Management's Ginkgo Bioworks position peaked at $168K in Q4 2021.
  • 315 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2023.

Based on Ionic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.